MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

sanity will prevail, page-21

  1. 3,176 Posts.
    goomoanerback stepping on mbp warren the other day we argued time lines for bios and ph2/ph3 trial u made out mbp was a done deal both in time frame to mkt and the ph2 trials

    ( which i was correct yet again )

    yet in the post bellow your saying exactly what i was saying earlier . in that mbp still has a long way to go and could potentially fail at ph3 . its simply not a done deal yet
    i feel sorry for people who bought on your rantings ( bio guru my butt cheek )
    thanks for agreeing with me bellow btw

    warren aka wassa aka kwami aka znison
    wrote

    Subject re: sanity will prevail
    Posted 16/12/04 06:54 - 41 reads
    Posted by goominer
    Post #459083 - in reply to msg. #459053

    gabothegreat been a memer for 1 week?
    someone has misunderstood the statistics
    this is phase 2b not phase 3 of the trial and hence the small no. of patients in the trial.
    the aim of the trial was to assess safety and tolerablity and weight loss and fat loss. This was not a phase 3 pivotal trial. For each of the primary endpoints (aims) the trial was positive. To answer definitively the question whether the drug is effective requires a phase 3 trial with sufficient numbers for the statistics to then be significant
    The results of this phase 2b trial more than justify proceeding to a phase 3 pivotal trial


    regards gaga
    ps most bios fail ph3

    newbies do your own research
 
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.